BJ

Bianca Ebony Jamar

Director Of Clinical Operations (global) at Meditrial

Bianca Ebony Jamar has a diverse work experience in the field of clinical research and administration. Bianca Ebony has held various roles in multiple organizations, including Meditrial, Planet Pharma, Weill Cornell Medicine, NewYork-Presbyterian Hospital, Hackensack University Medical Center, Icahn School of Medicine at Mount Sinai, U.S. Department of Veterans Affairs, Sadick Dermatology and Research Group, Pearl Pathways, and The Mount Sinai Hospital.

In their most recent position at Meditrial as the Director of Clinical Operations (Global), Bianca provides leadership in the development of protocols, clinical trial management plans, budgets, and resourcing strategies. Bianca Ebony collaborates with cross-functional teams to resolve monitoring errors and oversees clinical vendors and site regulatory staff.

Prior to that, Bianca worked as a Senior IRB Operations Manager at Planet Pharma, overseeing all stages of clinical trial conduct and ensuring compliance with IRB policies and federal regulations. Bianca Ebony also served as an IRB/PB Administrator at Weill Cornell Medicine and NewYork-Presbyterian Hospital, promoting awareness of ethical research conduct and safeguarding participants' rights and welfare.

Bianca has also held roles as a Clinical Research Education Specialist at Hackensack University Medical Center, a Research Program Manager at Icahn School of Medicine at Mount Sinai, a Research Development Program Manager at the U.S. Department of Veterans Affairs, and a Senior Clinical Research Coordinator at Sadick Dermatology and Research Group. In these positions, they contributed to the conduct of clinical studies, ensured compliance with regulations and guidelines, and coordinated various research activities.

Additionally, Bianca worked as a Senior IRB Operations Manager at Pearl Pathways, where they managed all stages of clinical trials and conducted preliminary reviews of IRB applications.

Earlier in their career, Bianca served as a Lead Clinical Research Coordinator at The Mount Sinai Hospital, where they worked on a clinical trial studying the relationship between hormones, sexual function, and cardiovascular outcomes in men with diabetes and coronary disease.

Overall, Bianca Ebony Jamar has extensive experience in clinical research operations, IRB administration, and regulatory compliance, making their a valuable asset in the field.

Bianca Ebony Jamar has an extensive education history. Bianca Ebony completed their doctoral studies at the CUNY Graduate School of Public Health and Health Policy, earning a Doctor of Philosophy (PhD) degree in Health Policy Analysis in 2022 and a second PhD degree in Public Health in 2022 as well. Prior to their doctoral studies, they pursued a Master of Public Health (MPH) degree in Health Policy & Management from the same institution, which they completed between 2014 and 2016. Bianca Ebony also pursued a Master of Public Health (MPH) degree in Epidemiology from 2012 to 2014.

Before their graduate studies, Jamar obtained their Bachelor of Science (B.S.) degree in Biology/Biological Sciences from New Jersey City University, which they completed from 2006 to 2012. Bianca Ebony also obtained a Bachelor of Arts (BA) degree in Chemistry from the same university from 2006 to 2010. Additionally, they pursued a Bachelor of Arts (B.A.) degree in Chemistry from William Paterson University of New Jersey from 2006 to 2008.

Bianca Ebony'seducational journey began at Piscataway High School, where they obtained their High School Diploma in 2002.

In addition to their academic achievements, Jamar has obtained certifications in CPR from the National Institutes of Health and in Phlebotomy from the Mount Sinai Health System. The specific months and years of when they obtained these certifications are not provided in the given information.

Links

Previous companies

Hackensack Meridian Health logo
NewYork-Presbyterian logo
The Mount Sinai Hospital logo
Icahn School of Medicine logo

Timeline

  • Director Of Clinical Operations (global)

    February, 2022 - present